E-LIB Suche - Ergebnisse für: Shin, Ho-Jin

1

Superior outcomes and high-risk features with carfilzomib, ..:

Lee, Ji Hyun ; Choi, Jimin ; Min, Chang-Ki...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

2

Geriatric risk model for older patients with diffuse large ..:

Yhim, Ho-Young ; Park, Yong ; Kim, Jeong-A...
The Korean Journal of Internal Medicine. 39 (2024) 3 - p. 501-512 , 2024

Link: https://doi.org/10.3904/..

3

Combination of acalabrutinib with lenalidomide and rituxima..:

Park, Changhee ; Lee, Ho Sup ; Kang, Ka-Won...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

4

Polatuzumab vedotin in previously untreated DLBCL: an Asia ..:

Song, Yuqin ; Tilly, Hervé ; Rai, Shinya...
Blood. 141 (2023) 16 - p. 1971-1981 , 2023

Link: https://doi.org/10.1182/..

5

P-279 Efficacy and safety of carfilzomib, lenalidomide, and..:

Kim, Do Young ; Shin, Ho-Jin ; Min, Chang-Ki...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S189-S190 , 2023

Link: https://doi.org/10.1016/..

6

P1098: A PHASE II, OPEN-LABEL, MULTICENTER STUDY OF CAPIVAS..:

Hodson, Daniel ; Shouse, Geoffrey ; Shin, Ho-Jin...
HemaSphere. 7 (2023) S3 - p. e5749555 , 2023

Link: https://doi.org/10.1097/..

7

Nation-Wide Retrospective Analysis of Allogeneic Stem Cell ..:

Shin, Ho-Jin ; Kim, Do-Young ; Kim, Kihyun...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S403-S404 , 2023

Link: https://doi.org/10.1016/..

8

Long-Term Efficacy and Safety of Eculizumab in Patients Wit..:

Kim, Jin Seok ; Jang, Jun Ho ; Jo, Deog-Yeon...
Journal of Korean Medical Science. 38 (2023) 41 - p. , 2023

Link: https://doi.org/10.3346/..

9

Transcriptomic analysis of neutrophil apoptosis induced by ..:

Jeon, Byeol-Eun ; Lee, Ji-Eun ; Park, Jungwook...
Genes & Genomics. 45 (2023) 8 - p. 1013-1024 , 2023

Link: https://doi.org/10.1007/..

10

Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Resul..:

Yi, Jun Ho ; Jeong, Seong Hyun ; Kim, Seok Jin...
Cancer Research and Treatment. 55 (2023) 1 - p. 325-333 , 2023

Link: https://doi.org/10.4143/..

11

Daratumumab plus bortezomib, cyclophosphamide, and dexameth..:

Suzuki, Kenshi ; Wechalekar, Ashutosh D. ; Kim, Kihyun...
Annals of Hematology. 102 (2023) 4 - p. 863-876 , 2023

Link: https://doi.org/10.1007/..

12

Busulfan, Melphalan, and Etoposide (BuME) Showed an Equival..:

Kim, Kyoung Ha ; Lee, Jae Hoon ; Lee, Mark...
Cancer Research and Treatment. 55 (2023) 1 - p. 304-313 , 2023

Link: https://doi.org/10.4143/..

13

P1042: COMPARISON OF THE RESPONSE TO ROPEGINTERFERON ALFA-2..:

Lee, Sung-Eun ; Yoon, Sung-Soo ; Yang, Deok-Hwan...
HemaSphere. 7 (2023) S3 - p. e86929d8 , 2023

Link: https://doi.org/10.1097/..

14

S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENO..:

Yahng, Seung-Ah ; Yhim, Ho-Young ; Kwak, Jae-Yong...
HemaSphere. 7 (2023) S3 - p. e60026bd , 2023

Link: https://doi.org/10.1097/..

15

Comparison of first-line treatment with CHOP versus ICED in..:

Kim, Seok Jin ; Jo, Jae-Cheol ; Yoon, Dok Hyun...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..